Results 211 to 220 of about 39,241 (241)

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Bacteroides fragilis and nitroimidazoles

Journal of Antimicrobial Chemotherapy, 1976
I R, Ferguson, L L, Smith
openaire   +2 more sources

Cefamandole against Bacteroides fragilis.

Scandinavian journal of infectious diseases. Supplementum, 1981
Cefamandole is a second-generation cephalosporin with a high level of activity against common aerobic pathogens, both Gram-positive and Gram-negative. Eighty-five per cent of 20 recent clinical isolates of Bacteroides fragilis are sensitive and these data allied with its known activity against common aerobes reinforce its recommendation for the ...
openaire   +1 more source

Clindamycin resistance in Bacteroides fragilis

Journal of Antimicrobial Chemotherapy, 1981
F P, Tally, A, Sosa, N V, Jacobus, M H, Malamy   +3 more
openaire   +2 more sources

Bacteroides fragilis resistant to clindamycin

Journal of Antimicrobial Chemotherapy, 1981
F, Soriano, M C, Ponte, M C, Gaspar
openaire   +2 more sources

METRONIDAZOLE RESISTANCE AMONG BACTEROIDES FRAGILIS

The Lancet, 1978
A T, Willis, P H, Jones, K D, Phillips, G, Gottobed   +3 more
openaire   +2 more sources

BACTEROIDES FRAGILIS MENINGITIS

The Lancet, 1977
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Bacteroides fragilis toxins

2006
Cynthia L. Sears, Augusto A. Franco, Shaoguang Wu   +2 more
openaire   +1 more source